(19)
(11) EP 4 042 441 A1

(12)

(43) Date of publication:
17.08.2022 Bulletin 2022/33

(21) Application number: 20872387.4

(22) Date of filing: 02.10.2020
(51) International Patent Classification (IPC): 
G16H 40/40(2018.01)
G16H 40/60(2018.01)
G16H 20/17(2018.01)
G16H 15/00(2018.01)
G16H 40/67(2018.01)
(52) Cooperative Patent Classification (CPC):
G16H 40/40; G16H 20/17; G16H 40/67; G16H 40/63; G16H 50/20; G16H 15/00; A61B 5/14532; A61B 5/4839; G06F 8/65; A61M 2005/14208; A61M 5/172; A61M 5/1723; A61M 5/14244; A61M 2205/502; A61M 2205/18; A61M 2230/201; A61M 2205/3592; A61M 2205/3584; A61M 2205/3569; A61M 2205/3553; A61M 2205/3303
(86) International application number:
PCT/US2020/054025
(87) International publication number:
WO 2021/067767 (08.04.2021 Gazette 2021/14)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 04.10.2019 US 201962910970 P
04.10.2019 US 201962911017 P
04.10.2019 US 201962911143 P
10.03.2020 US 202062987842 P
10.06.2020 US 202063037472 P
15.07.2020 WO PCT/US2020/042195
15.07.2020 WO PCT/US2020/042198
16.07.2020 WO PCT/US2020/042269

(71) Applicant: Beta Bionics, Inc.
Irvine, California 92618 (US)

(72) Inventors:
  • DAMIANO, Edward R.
    Acton, Massachusetts 01720 (US)
  • EL-KHATIB, Firas H.
    Alston, Massachusetts 02134 (US)
  • ROSINKO, Michael J.
    Anaheim, California 92808 (US)
  • BROWN, Justin P.
    Tustin, California 92782 (US)
  • LIM, David Chi-Wai
    Irvine, California 92620 (US)
  • KNODEL, Bryan Dale
    Flagstaff, Arizona 86001 (US)
  • PATEL, Himanshu
    Santa Margarita, California 92688 (US)
  • COSTIK, John, R.
    Livonia New York 14487 (US)

(74) Representative: Hertin und Partner Rechts- und Patentanwälte PartG mbB 
Kurfürstendamm 54/55
10707 Berlin
10707 Berlin (DE)

   


(54) BLOOD GLUCOSE CONTROL SYSTEM